Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis
- Registration Number
- NCT00592566
- Lead Sponsor
- Mahidol University
- Brief Summary
Background: Pulmonary involvement in leptospirosis has been reported to be on the increase and is emerging as the main cause of death due to leptospirosis in many countries, including Thailand.
Methods: A prospective randomized controlled trial of desmopressin or high dose dexamethasone as adjunctive therapy in patients with suspected pulmonary hemorrhage associated with leptospirosis was conducted between July 2003 and October 2006 at 5 hospitals in Thailand.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
- adult patients (> 14 years) with suspected severe leptospirosis
- patients who presented with acute fever (oral temperature more than 38.00 C for <15 days) in the absence of an obvious focus of infection
- In the opinion of the attending physician might have pulmonary hemorrhage (i.e. history of hemoptysis, and/ or bilateral nodular or air space infiltration).
Read More
Exclusion Criteria
- pregnant or breastfeeding
- those with history of bleeding disorder
- those who had underlying diseases such as chronic liver disease, diabetes mellitus
- those who received diuretic or glucocorticoid
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Dexamethasone, desmopressin Dexamethasone treatment 3 Dexamethasone, desmopressin Desmopressin treatment
- Primary Outcome Measures
Name Time Method Survival during in hospital admission
- Secondary Outcome Measures
Name Time Method Days of mechanical ventilation during hospital admission
Trial Locations
- Locations (1)
Loei Hospital
🇹ðŸ‡Mueng, Loei Province, Thailand